Document Viewer
Share this page:
Title
Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of FRESENIUS PROPOVEN 2% Emulsion
Subject
Description
EUA: To maintain sedation via continuous infusion in patients older than age 16 with suspected or confirmed COVID-19 who require mechanical ventilation in an ICU setting 2
Date Last Updated (Year-Month-Day)
2020-05-08
Citation
Download Heathcare Providers Fact Sheet directly: https://www.fda.gov/media/137889/download
Download Patients, Parents, and Caregivers Fact Sheet directly: https://www.fda.gov/media/137890/download